238 related articles for article (PubMed ID: 7642409)
1. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
[TBL] [Abstract][Full Text] [Related]
3. KIN-804 vs. KU-2285 as a radiosensitizer for clinical use.
Oya N; Shibamoto Y; Shibata T; Murata R; Iwai H; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):595-600. PubMed ID: 8005822
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
[TBL] [Abstract][Full Text] [Related]
6. [Radiosensitizing effects of nitroimidazole derivative, KIN-804].
Tada T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):70-5. PubMed ID: 7899069
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
[TBL] [Abstract][Full Text] [Related]
8. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated 2-nitroimidazole derivative hypoxic cell radiosensitizers: radiosensitizing activities and pharmacokinetics.
Sasai K; Iwai H; Yoshizawa T; Nishimoto S; Shibamoto Y; Oya N; Shibata T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):579-82. PubMed ID: 8005818
[TBL] [Abstract][Full Text] [Related]
10. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643
[TBL] [Abstract][Full Text] [Related]
11. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
[TBL] [Abstract][Full Text] [Related]
12. In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses.
Oya N; Shibamoto Y; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1113-9. PubMed ID: 8262836
[TBL] [Abstract][Full Text] [Related]
13. Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses.
Shibata T; Shibamoto Y; Oya N; Sasai K; Murata R; Ishigaki T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):587-90. PubMed ID: 8005820
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice.
Iwai H; Matsuno E; Sasai K; Shibamoto Y; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):591-4. PubMed ID: 8005821
[TBL] [Abstract][Full Text] [Related]
15. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
17. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
[TBL] [Abstract][Full Text] [Related]
18. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and radiosensitizing effect of PR-350.
Hirokawa K; Nakajima T; Tsumura M; Nishita T; Yamada R; Onoyama Y
Radiat Med; 1997; 15(1):45-9. PubMed ID: 9134584
[TBL] [Abstract][Full Text] [Related]
20. The radiosensitizing effects of hypoxic cell sensitizer on SCCVII tumors in mice evaluated by highly accurate colony formation assay assisted by microcomputer.
Ono K; Akuta K; Masunaga S; Kinashi Y; Suzuki M
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1066-70. PubMed ID: 9014470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
